期刊文献+

大鼠脑局灶性缺血再灌注后梗死体积变化与低分子肝素的保护效应 被引量:2

Protective effect of low molecular heparin on infarct volume after focal cerebral ischemia/reperfusion in rats
下载PDF
导出
摘要 目的:观察低分子肝素对大鼠脑缺血再灌注后不同时间点脑梗死体积的影响。方法:实验于2005-03/2005-06在华北煤炭医学院动物实验中心完成。①选用雄性SD大鼠90只,体质量280~330g。应用随机数字表法将大鼠分为3组:假手术组、缺血再灌注组、低分子肝素组,每组30只。假手术组:只游离右侧颈总动脉、颈内动脉、颈外动脉。缺血再灌注组和低分子肝素组:均采用改良Longa法制作大鼠右侧大脑中动脉闭塞局灶性脑缺血再灌注模型。缺血2h后分别腹腔注射生理盐水1mL和皮下注射低分子肝素(200IU/kg)生理盐水稀释液1mL。2组均于缺血2.5h后开始再灌注3,6,12,24,48h,每个时间点取6只进行观察。②分别称重应用四氮唑红染色法染成白色的梗死组织与染成红色的正常组织,以梗死组织占全脑湿重的百分比表示脑梗死体积。③采用两样本均数的t检验对两组间数据进行分析。结果:大鼠90只均进入结果分析。缺血再灌注组大鼠脑缺血再灌注3,6,12,24,48h时脑梗死体积分别为(17.28±2.69)%,(22.66±2.16)%,(30.17±4.17)%,(38.83±4.54)%,(43.75±2.66)%,低分子肝素组分别为(12.54±1.35)%,(19.83±2.32)%,(23.83±3.19)%,(30.33±2.50)%,(36.25±2.54)%,假手术组均为0。随着缺血再灌注时间的延长,缺血再灌注组脑梗死体积逐渐增大,低分子肝素组梗死体积较缺血再灌注同一时间组明显缩小(t=-2.376,-2.191,-2.96,-4.019,-4.446,P<0.05)。结论:脑缺血再灌注损伤随再灌注时间延长而加重,低分子肝素能减少脑梗死体积,缩小梗死范围,对大鼠脑缺血再灌注损伤后具有保护作用。 AIM: To study the effect of low molecular weight heparin on the cerebral infarct volume after local cerebral ischemia/raperfusion in rats at different time point. METHODS: The experiment was performed at the Animal Experimental Center of North China Coal Medical College from March to June 2005. ①Totally 90 male SD rats, with the body mass of 280-330 g were selected and randomly assigned into 3 groups: sham operation group, ischemia/reperfusion group, low molecular weight heparin group with 30 in each group. Sham operation group only received common carotid artery, internal carotid artery, and external carotid artery of right side isolation. Middle cerebral artery occlusion and focal cerebral ischemia/raperfusion models were established with modified Longa method in the right side of rats in the ischemia/reperfusion group and low molecular weight heparin group. 2 hours after ischemia 1 mL saline was injected with intraperitoneal injection and 1 mL(200 IU/kg) low molecular heparin saline dilution was injected with subcutaneous injection. Six rats were observed at each time point for reperfusion at hours 3, 6, 12, 24 and 48 after ischemia for 2.5 hours in the two groups. ②Infarcted tissues stained white and normal tissues stained red with TTC stain were weighed, respectively. Cerebral infarct volume was expressed with the percentage of infarcted tissues to wet weight of the whole brain. ③All data in the two groups were analyzed with t test. RESULTS: Totally 90 rats were involved in the result analysis. The cerebral infarct volume was (17.28±2.69)%,(22.66± 2.16)%,(30.17±4.17)%,(38.83±4.54)%,(43.75±2.66)%, respectively in the ischemia/reperfusion group, and (12.54± 1.35)% ,(19.83±2.32)% ,(23.83±3.19)% ,(30.33±2.50)%,(36.25±2.54)% in the low molecular heparin group, and it was 0 in the sham operation group at hours 3, 6, 12, 24 and 48 after cerebral ischemia/reperfusion. With the prolongation of ischemia/reperfusion duration, the cerebral infarct volume became large gradually in the ischemia/reperfusion group, and the volume became small markedly in the low molecular heparin group as compared with the ischemia/reperfusion group at the same time point (t =-2.376,-2.191 ,-2.96,-4.019,-4.446,P 〈 0.05). CONCLUSION: The cerebral ischemia/reperfusion injury becomes severe with the prolongation of reperfusion duration. Low molecular heparin can reduce cerebral infarct volume, contract infarct range, and and have the protective effects after cerebral ischemia/reperfusion injury in rats.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2007年第8期1522-1524,共3页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献17

  • 1Tsuchidate R,He QP,Smith ML,et al.Regional cerebral blood flow during and after 2 hours of middle cerebral artery occlusion in the rat.J Cereb Blood Flow Metab 1997;17(10):1066-1073
  • 2Longa EZ,Weinstein PR,Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke 1989;20(1):84-91
  • 3Hovanessian HC.New-generation anticoagulants:the low molecular weight heparins.Ann Emerg Med 1999;34(6):768-779
  • 4Vanpee D,Gillet JB,Swine C.Low molecular weight heparin.Ann Emerg Med 2000;36(3):277-278
  • 5秦献辉,李莹,何晓静,刘玉兰.低分子肝素对大鼠局灶性脑缺血再灌注损害的保护作用[J].沈阳药科大学学报,2004,21(3):207-209. 被引量:7
  • 6上海市急性脑血管病规范化治疗协作组.低分子肝素治疗急性脑梗死的前瞻性多中心随机对照临床研究[J].中国临床神经科学,2003,11(2):175-177. 被引量:15
  • 7McBride WT,Armstrong MA,McMurray TJ.An investigation of the effects of heparin,low molecular weight heparin,protamine,and fentanyl on the balance of pro-and anti-inflammatory cytokines in in-vitro monocyte cultures.Anaesthesia 1996;51(7):634-640
  • 8Quartermain D,Li Y,Jonas S.Enoxaparin,a low molecular weight heparin decreases infarct size and improves sensorimotor function in a rat model of focal cerebral ischemia.Neurosci Lett 2000;288(2):155-158
  • 9Quartermain D,Li YS,Jonas S.The low molecular weight heparin enoxaparin reduces infarct size in a rat model of temporary focal ischemia.Cerebrovasc Dis 2003; 16(4):346-355
  • 10Wahl F,Grosjean-Piot O,Bareyre F,et al.Enoxaparin reduces brain edema,cerebral lesions,and improves motor and cognitive impairments induced by a traumatic brain injury in rats.J Neurotrauma 2000;17(11):1055-1065

二级参考文献31

  • 1Kay R, Wong KS, Yu YL, et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke[J]. N Engl J Med 1995,333:1588-1593.
  • 2Hart RG, Easton JD, Do we really head a beher way to give heparin in acute cerebral ischemia? [ J ]. Stroke, 2000, 33 : 659-660.
  • 3The publication committee for the trial of ORG 10172 in acute stroke treatment (TOAST) investigators. Low molecular weight heparinoid, OGR 10172(danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial[J] .JAMS, 1998,279:1265-1272.
  • 4International Stroke Trial Collaborative Group. The international stroke trial(1ST) : a randomised trial og aspirin, subcutaneous heparin, both, or neither among 19435 patients gith acute ischaemic stroke[J]. Lancet, 1997,349:1569-1581.
  • 5Philip M, WB Robert 1, Fiona JB. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomizd controlled trials[J]. Stroke,2000,31 : 1770-1778.
  • 6Diener HC, Ringelstein EB, Kammer RV, et al.Treatment of acute stroke with the low-molecular-weight heparin certoparin. Results of the TOPAS trial[ J]. Stroke, 2001,32: 22-29.
  • 7Berge E. Ahdelnoor M, Nakstad PH, et al. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation:a doubel-blind randomized study. HAEST Study Group. Heparin in acute embolic stroke trial . Lancet 2000, 355(9211 ) : 1205-1210.
  • 8Lensing WA, Prins MH, Davidson BL, et al. Treatment of deep venous thrombosis with low-molecular-weight heparins: a meta-analysis [ J ]. Arch Interm Med, 1995,155:601-607.
  • 9Longa EZ,Weinetein PR,Carson S,et al.Reversible middle cerbral artery occlusion without craniectomy in rats [J].Stroke,1999,20(10):84-89.
  • 10Koizumi J,Yoshida Y,Nakazawa T,et al.Experimental studies of ischemic brain edema;A new experimental model of cerebral embolism in rats in which recirulation can be introduced in the ischemic area [J].Jpn J Stroke,1986,8:1-8.

共引文献37

同被引文献10

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部